You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海思科(002653.SZ):海思科新加坡公司擬獲增資2.69億元 用於購買HSK3486在中國內地以外專有技術所有權
格隆匯 03-05 17:40

格隆匯 3 月 5日丨海思科(002653.SZ)公佈,公司第四屆董事會第十五次會議於2021年3月5日以通訊表決方式召開,會議通過了《關於全資子公司對其控股子公司增資的議案》。

(1)公司全資子公司四川海思科製藥有限公司(“四川海思科”)以自有資金對其全資子公司HAISCO HOLDINGS PTE.LTD.(“海思科控股”)增資人民幣約2.15億元。

(2)海思科控股以自有資金對其控股子公司HAISCO PHARMACEUTICALHOLDINGS GROUP LIMITED(“海思科開曼公司”)增資人民幣約2.15億元。

(3)公司關聯公司HAISIGHT HOLDINGS PTE.LTD.(“海賽特控股”)以自有資金對海思科開曼公司增資人民幣5374.6萬元。

(4)海思科開曼公司以自有資金對其全資子公司HAISCO INNOVATIVEPHARMACEUTICAL PTE.LTD.(“海思科新加坡公司”)增資人民幣2.6873億元。

此次增資將用於海思科新加坡公司從四川海思科購買HSK3486乳狀注射液鎮靜/麻醉藥物在中國內地以外市場(含港澳台)的專有技術所有權,有助於海思科創新藥在境外的臨牀試驗和上市運營。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account